Randomized phase II trial of docetaxel plus irinotecan versus docetaxel plus 5-fluorouracil (5FU) in patients with untreated advanced gastric adenocarcinoma (AGAC). - Hawkins,R.; Cunningham,D.; Soerbye,H. (Proc ASCO, 2003)